Living 2B Unleashed Formula Capsules
Natural health product licensed in Canada
- Other names
- 2B Unleashed, 2B Unleashed Formula
- Licence holder
- Living 2B Canada LLC
- NPN or DIN-HM
- 80087013
- Status
- Inactive licence
- Licence date
- 11 July 2018
- Revision date
- 26 July 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 20 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 20 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ocimum basilicum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les enfants et une mention déconseillant un usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Extrait de Feuille Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100 mg | Not calculated |
| Withania somnifera Source : Leaves (standardized extract) Potency : 8 % Withanolide glycoside conjugates | 200 mg | Not calculated |
| Withania somnifera Source : Leaves (standardized extract) Potency : 32 % Oligosaccharides | Not specified | Not calculated |
| Withania somnifera Source : Root (standardized extract) Potency : 8 % Withanolide glycoside conjugates | 200 mg | Not calculated |
| Ocimum basilicum Source : Feuille | 2.5 mg | Not calculated |
| Hericium erinaceus Source : Corps fructifère | 2.5 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 5 mg | 20,000 µg |
| Withania somnifera Source : Root (standardized extract) Potency : 32 % Oligosaccharides | Not specified | Not calculated |
Non-medicinal ingredients
cellulose, Riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in energy metabolism and in tissue formation. Helps in the normal function of the immune system. Helps to form red blood cells. Helps to maintain the body's ability to metabolize nutrients. Helps to prevent vitamin B12 deficiency. Helps to prevent vitamin B6 deficiency. Helps energy metabolism in the body. Source of fungal polysaccharides with immunomodulating properties.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80087013
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging